This inventor holds 2 USPTO granted patents. Top assignee: University of California. Active years: 2014-2017.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2014-2017
Title: Innovations by Sarah E Cross
Introduction
Sarah E Cross is an accomplished inventor based in El Granada, California. She has made significant contributions to the field of biomedical research, particularly in the analysis of ex vivo cells for disease detection and therapeutic monitoring. With a total of two patents to her name, her work is paving the way for advancements in cancer diagnostics and treatment.
Latest Patents
One of her latest patents focuses on the analysis of ex vivo cells for disease state detection and therapeutic agent selection and monitoring. This patent describes the analysis of nanomechanical characteristics of cells. Changes in certain local nanomechanical characteristics of ex vivo human cells can correlate with the presence of diseases, such as cancer, as well as the particular stage of disease progression. Additionally, for patients administered with therapeutic agents, changes in local nanomechanical characteristics of ex vivo cells can indicate the effectiveness of the treatment in impeding or reversing disease progression. By exploiting this correlation, systems and related methods can be implemented for disease state detection and therapeutic agent selection and monitoring.
Career Highlights
Sarah E Cross is affiliated with the University of California, where she continues her research and innovation in the field of biomedical engineering. Her work has garnered attention for its potential to revolutionize how diseases are detected and treated.
Collaborations
Some of her notable coworkers include James K Gimzewski and Yusheng Jin, who contribute to her research endeavors and collaborative projects.
Conclusion
Sarah E Cross is a pioneering inventor whose work in the analysis of ex vivo cells is making significant strides in disease detection and therapeutic monitoring. Her contributions are essential in advancing medical science and improving patient outcomes.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
